Department of Internal Medicine, University of Medical Sciences, Ondo State, Nigeria.
Department of Internal Medicine, University of Benin Teaching Hospital, Edo State, Nigeria.
PLoS One. 2024 Jun 11;19(6):e0304633. doi: 10.1371/journal.pone.0304633. eCollection 2024.
Intradialytic hypertension (IDHTN) is a common but less frequently recognised complication of haemodialysis. However, it is associated with increased overall mortality in patients on haemodialysis. This systematic review and meta-analysis aimed to determine the prevalence of IDHTN and associated mortality risk in the global haemodialysis population.
A systematic search of PubMed and EMBASE was undertaken to identify articles with relevant data published between 1990 and 2023. The pooled prevalence of IDHTN in the global haemodialysis population was determined using the DerSimonian-Laird random-effects meta-analysis. The pooled hazards ratio for mortality in patients with IDHTN was also computed from the studies that reported mortality among haemodialysis patients with IDHTN. The study protocol was registered with PROSPERO (CRD42023388278).
Thirty-two articles from 17 countries were included, with a pooled population of 127,080 hemodialysis patients (median age 55.1 years, 38.2% females). Most studies had medium methodological quality (53.1%, n = 17). The overall pooled prevalence of IDHTN was 26.6% [(95% CI 20.2-33.4%), n = 27 studies, I2 = 99.3%, p<0.001 for heterogeneity], with significant differences depending on the definition used. The pooled proportion of haemodialysis sessions with IDHTN was 19.9% [(95% 12.5-28.6%, n = 8 studies, I2 = 99.3%, p<0.001 for heterogeneity)] with significant differences across the different definition criteria. The p-value for the Begg test was 0.85. The median pre-dialysis blood pressure was not significantly associated with IDHTN. The pooled hazard ratio for mortality was 1.37 (95% CI 1.09-1.65), n = 5 studies, I2 = 13.7%, and p-value for heterogeneity = 0.33.
The prevalence of IDHTN is high and varies widely according to the definition used. A consensus definition of IDHTN is needed to promote uniformity in research and management. The increased mortality risk forecasted by IDHTN highlights the need for optimal blood pressure control in patients on hemodialysis.
透析中高血压(IDHTN)是血液透析患者常见但较少被认识到的并发症。然而,它与血液透析患者的总死亡率增加有关。本系统评价和荟萃分析旨在确定全球血液透析人群中 IDHTN 的患病率及其与死亡率的相关性。
对 PubMed 和 EMBASE 进行系统检索,以确定 1990 年至 2023 年期间发表的具有相关数据的文章。使用 DerSimonian-Laird 随机效应荟萃分析确定全球血液透析人群中 IDHTN 的患病率。还从报告 IDHTN 血液透析患者死亡率的研究中计算了 IDHTN 患者的死亡率的合并危险比。该研究方案已在 PROSPERO(CRD42023388278)上注册。
纳入了来自 17 个国家的 32 篇文章,共有 127080 名血液透析患者的汇总人群(中位年龄 55.1 岁,38.2%为女性)。大多数研究具有中等方法学质量(53.1%,n=17)。IDHTN 的总体汇总患病率为 26.6%[(95%CI 20.2-33.4%),n=27 项研究,I2=99.3%,p<0.001 用于异质性],且存在显著差异取决于使用的定义。IDHTN 血液透析次数的汇总比例为 19.9%[(95%CI 12.5-28.6%),n=8 项研究,I2=99.3%,p<0.001 用于异质性],不同定义标准之间存在显著差异。贝格检验的 p 值为 0.85。预透析时的血压中位数与 IDHTN 无显著相关性。死亡率的合并危险比为 1.37(95%CI 1.09-1.65),n=5 项研究,I2=13.7%,异质性检验 p 值=0.33。
IDHTN 的患病率较高,且根据使用的定义差异很大。需要对 IDHTN 进行共识定义,以促进研究和管理的一致性。IDHTN 预测的死亡率升高突显了血液透析患者血压控制的重要性。